Sch Safety Questions, Sch Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about Sch side effects. Our extensive database of Sch adverse events and Sch warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Doctors about Sch
Sch Safety Reports
Total Sch reports: 10.Sch FDA safety alerts: 2001 2002 2003 2004 2005 2006 2007 .
Reported deaths: 1 Reported hospitalizations: 8.
Take Sch Side Effects Survey or Share Your Sch Story.
Reported Sch Side Effects: dehydration, diarrhoea, bacterial infection, anaemia, blood potassium decreased, blood glucose increased, blood culture positive, blood albumin decreased, nerve root compression, muscular weakness, intervertebral disc protrusion.
Read More Here.
Physician from UNITED STATES reported SCH problem on May 24, 2007. Female patient, 44 years of age, weighting 144.6 lb, was diagnosed with hepatitis c and was treated with SCH. After drug was administered, patient experienced the following problems/side effects: anaemia, bacterial infection, blood albumin decreased, blood culture positive, blood glucose increased, blood potassium decreased, blood sodium decreased, dehydration, diarrhoea. SCH dosage: 800 MG;TID;PO. During the same period patient was treated with RIBAVIRIN, LEVOTHYROXINE, ESCITALOPRAM OXALATE, ALPRAZOLAM, PHENERGAN. Patient was hospitalized. Patient recovered.
SCH problem was reported by a Physician from UNITED STATES on June 13, 2007. Female patient, 44 years of age, weighting 144.6 lb, was diagnosed with hepatitis c and was treated with SCH. After drug was administered, patient experienced the following problems/side effects: anaemia, bacterial infection, blood albumin decreased, blood culture positive, blood glucose decreased, blood potassium decreased, dehydration, diarrhoea, dysarthria. SCH dosage: 800 MG; TID; PO. During the same period patient was treated with RIBAVIRIN, LEVOTHYROXINE, ESCITALOPRAM, ALPRAZOLAM, PHENERGAN, LAXATIVES, ULTRAM. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported SCH problem on Aug 28, 2006. Female patient, 60 years of age, weighting 143.0 lb, was diagnosed with hepatitis c and was treated with SCH. After drug was administered, patient experienced the following problems/side effects: abdominal discomfort, asthenia, dehydration, fatigue, haematocrit decreased, haemoglobin decreased, heart rate increased, lung hyperinflation, nausea. SCH dosage: 400 MG; TID; PO; SEE IMAGE. During the same period patient was treated with REBETOL, ACTONEL, PROTONIX, CALCIUM W, VITAMIN E. Patient recovered.
SCH problem was reported by a Physician from UNITED STATES on May 24, 2007. Female patient, 44 years of age, weighting 144.6 lb, was diagnosed with hepatitis c and was treated with SCH. After drug was administered, patient experienced the following problems/side effects: anaemia, bacterial infection, blood albumin decreased, blood culture positive, blood glucose increased, blood potassium decreased, blood sodium decreased, dehydration, diarrhoea. SCH dosage: 800 MG;TID;PO. During the same period patient was treated with RIBAVIRIN, LEVOTHYROXINE, ESCITALOPRAM OXALATE, ALPRAZOLAM, PHENERGAN. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported SCH problem on June 13, 2007. Female patient, 44 years of age, weighting 144.6 lb, was diagnosed with hepatitis c and was treated with SCH. After drug was administered, patient experienced the following problems/side effects: anaemia, bacterial infection, blood albumin decreased, blood culture positive, blood glucose increased, blood potassium decreased, confusional state, constipation, dehydration. SCH dosage: 800 MG; TID; PO. During the same period patient was treated with RIBAVIRIN, LEVOTHYROXINE, ESCITALOPRAM, ALPRAZOLAM, PHENERGAN, LAXATIVES, ULTRAM. Patient was hospitalized. Patient recovered.
SCH problem was reported by a Physician from UNITED STATES on June 27, 2007. Female patient, 44 years of age, weighting 144.6 lb, was diagnosed with hepatitis c and was treated with SCH. After drug was administered, patient experienced the following problems/side effects: anaemia, bacterial infection, blood glucose increased, confusional state, constipation, dehydration, diarrhoea, dysarthria, dystonia. SCH dosage: 800 MG; TID; PO. During the same period patient was treated with RIBAVIRIN, LEVOTHYROXINE, ESCITALOPRAM OXALATE, ALPRAZOLAM, PHENERGAN, LAXATIVES, ULTRAM. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported SCH problem on July 20, 2007. Male patient, 40 years of age, weighting 228.0 lb, was diagnosed with hepatitis c and was treated with SCH. After drug was administered, patient experienced the following problems/side effects: amphetamines positive, cellulitis, substance abuse. SCH dosage: 800 MG;. During the same period patient was treated with RIBAVIRIN. Patient died on 07/19/2007.
SCH problem was reported by a Physician from UNITED STATES on Aug 01, 2007. Female patient, 49 years of age, weighting 102.0 lb, was diagnosed with hepatitis c and was treated with SCH. After drug was administered, patient experienced the following problems/side effects: arthralgia, cerebral ischaemia, cerebrovascular accident, hemiparesis, intervertebral disc protrusion, muscular weakness, nerve compression, nerve root compression, nervous system disorder. SCH dosage: 400 MG; TID; PO. During the same period patient was treated with LORCET, VALIUM, PLAVIX, EPOGEN. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported SCH problem on Aug 13, 2007. Female patient, 49 years of age, weighting 102.0 lb, was diagnosed with hepatitis c and was treated with SCH. After drug was administered, patient experienced the following problems/side effects: arthralgia, intervertebral disc protrusion, muscular weakness, nerve root compression, no therapeutic response, oedema peripheral, radial nerve palsy, spinal column stenosis, spinal osteoarthritis. SCH dosage: 400 MG; TID; PO. During the same period patient was treated with LORCET, VALIUM, PLAVIX, EPOGEN. Patient was hospitalized. Patient recovered.
SCH problem was reported by a Physician from UNITED STATES on Sept 18, 2007. Male patient, 50 years of age, weighting 170.0 lb, was diagnosed with hepatitis c and was treated with SCH. After drug was administered, patient experienced the following problems/side effects: diarrhoea, heart rate increased, hypotension, hypovolaemia, mental status changes, nausea, pneumonia, renal failure, unevaluable event. SCH dosage: 800 MG; TID; PO. During the same period patient was treated with RIBAVIRIN, FOLIC ACID, ACETAMINOPHEN, PROTONIX, CLARINEX. Patient was hospitalized. Patient recovered.